USPTO serial 90499224
STELLA
Reviewed by CopyMark Law Group
Status 654
- Filing date
- Status date
- Registration date
- —
- Examiner
- DEFORD, JEFFREY S
- Law office
- TMO LAW OFFICE 115
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with STELLA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Computer programming in the medical field; Consulting services in the field of providing online, non-downloadable software and applications; Medical research; Medical research services; Medical research services in the field of cancer; Medical and scientific research in the field of medical imaging; Medical and scientific research in the field of management and detection, improvement and prevention of postpartum depression and other behavioral health problems in various life stages of women; Medical and scientific research in the field of behavioral health problems in various life stages of women; Medical and scientific research information in the field of management and detection, improvement and prevention of postpartum depression and other behavioral health problems in various life stages of women; Medical and scientific research information in the field of behavioral health problems in various life stages of women; Research and development in the field of prescription digital therapeutics targeting serious medical conditions; Research and development in the field of prescription drug consulting software; Research and development in the field of optimizing the cost-effectiveness of drug prescription plans for others including the use of generic, formulary, and non-formulary drug alternatives; Research and development of computer software; Research and development of new products; Research and development of technology in the field of prescription digital therapeutics targeting serious medical conditions; Research and development of technology in the field of identifying drugs as recommended replacements; Research and development of technology in the field of prescription of therapeutic exercise programs; Research in the field of Prescription drug consulting software; Research in the field of optimizing the cost-effectiveness of drug prescription plans for others including the use of generic, formulary, and non-formulary drug alternatives; Compiling data for research purposes in the field of medical science and medical consultancy; Computer software consulting; Providing medical research and scientific research information in the field of oncology via the Internet; Providing a web site featuring technology that enables physicians to generate, manage and exchange medical information and documents regardless of medical organization or geographic location; Providing an interactive web site featuring technology that enables users to enter, access, track, monitor and generate health and medical information and reports; Providing information about medical research; Providing information about medical research via a website; Providing information about medical and scientific research; Providing information about medical and scientific research via a website; Scientific research; Scientific research consulting in the field of prescription digital therapeutics targeting serious medical conditions; Scientific research consulting in the field of optimizing the cost-effectiveness of drug prescription plans for others including the use of generic, formulary, and non-formulary drug alternatives; Technical research in the field of pharmaceutical studies; Technology research in the field of management and detection, improvement and prevention of postpartum depression and other behavioral health problems in various life stages of women; Technology research in the field of behavioral health problems in various life stages of women | ACTIVE | Jul 7, 2020 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 16, 2026 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Jun 8, 2026 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Dec 9, 2025 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Dec 8, 2025 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Jun 3, 2025 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Apr 14, 2025 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Oct 2, 2024 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Mar 8, 2024 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Sep 8, 2023 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Feb 21, 2023 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Aug 17, 2022 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Feb 11, 2022 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Feb 11, 2022 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Feb 11, 2022 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Feb 10, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 10, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 10, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 30, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 30, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 30, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 19, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| May 3, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 3, 2021 | NWAP | NEW APPLICATION ENTERED | — |